S

Samik Pharm Co Ltd
KOSDAQ:014950

Watchlist Manager
Samik Pharm Co Ltd
KOSDAQ:014950
Watchlist
Price: 5 600 KRW -2.27% Market Closed
Market Cap: ₩56.1B

Intrinsic Value

The intrinsic value for Samik Pharm Co Ltd (014950) under the Base Case is 8 133.28 KRW. Compared with the current market price of 5 600 KRW, the stock appears Undervalued by 31% .

Intrinsic value calculated using DCF
₩8 133.28
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
8 133.28
Undervaluation 31%
Intrinsic Value
Price ₩5 600
S
Monitor Samik Pharm Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩6 506.62
Get notified when the price drops into your buy zone
Intrinsic Value ₩8 133.28
Margin of Safety 20% ₩6 506.62
Current Price ₩5 600
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Samik Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Samik Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Samik Pharm Co Ltd.

Explain Valuation
Alternatives to Samik Pharm Co Ltd

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Samik Pharm Co Ltd

Efficiency

Earnings Waterfall
Samik Pharm Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Samik Pharm Co Ltd stock?

The intrinsic value for Samik Pharm Co Ltd (014950) under the Base Case is 8 133.28 KRW.

Is Samik Pharm Co Ltd stock undervalued or overvalued?

Compared with the current market price of 5 600 KRW, the stock appears Undervalued by 31% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett